Myricetin and methyl eugenol combination enhances the anticancer activity, cell cycle arrest and apoptosis induction of cis-platin against HeLa cervical cancer cell lines

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 2, 2015, Pages 1116-1127

  Yi, Jin Ling ^a   Shi, Song ^a   Shen, Yan Li ^a   Wang, Ling ^a   Chen, Hai Yan ^a   Zhu, Jun ^a   Ding, Yan ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle; Cervical cancer; Combination therapy; Methyl eugenol; Myricetin

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CISPLATIN; DRUG COMBINATION; EUGENOL; FLAVONOID; METHYLEUGENOL; MYRICETIN;

ANALOGS AND DERIVATIVES; APOPTOSIS; CELL CYCLE; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; CELL SURVIVAL; DRUG COMBINATION; DRUG EFFECTS; DRUG INTERACTION; DRUG POTENTIATION; FEMALE; HELA CELL LINE; HUMAN; METABOLISM; UTERINE CERVICAL NEOPLASMS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CASPASE 3; CELL CYCLE; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; CELL SURVIVAL; CISPLATIN; DRUG COMBINATIONS; DRUG INTERACTIONS; DRUG SYNERGISM; EUGENOL; FEMALE; FLAVONOIDS; HELA CELLS; HUMANS; UTERINE CERVICAL NEOPLASMS;

EID: 84928138080     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Bellone S, Pecorelli S, Cannon MJ, Santin AD. Advances in dendritic-cell-based therapeutic vaccines for cervical cancer. Expert Rev Anticancer Ther 2007; 7: 1473-1486.
3. Leitao MM Jr, Chi DS. Recurrent cervical cancer. Curr Treat Options Oncol 2002; 3: 105-111.
4. Friedlander M. Guidelines for the treatment of recurrent and metastatic cervical cancer. Oncologist 2002; 7: 342-347.
5. Quinn MA, Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, Heintz AP, Ngan HY, Pecorelli S. Carcinoma of the cervix uteri. Int J Gynecol Obstet 2006; 95: 43-103.
6. Kumar V, Abbas AK, Fausto N, Mitchell RN. Robbins Basic Pathology. 8th edition. Saunders Elsevier; 2007.
7. Holland-Frei cancer medicine. 8th edition. New York: McGraw-Hill Medical; 2009.
8. Dunne EF, Park IU. HPV and HPV-associated diseases. Infect Dis Clin North Am 2013; 27: 765-78.
9. Dornhöfer N, Höckel M. New developments in the surgical therapy of cervical carcinoma. Ann NY Acad Sci 2008; 1138: 233-252.
10. Chao A, Lin CT, Lai CH. Updates in systemic treatment for metastatic cervical cancer. Curr Treat Options Oncol 2014; 15: 1-13.
11. Eskander RN, Tewari KS. Chemotherapy in the treatment of metastatic, persistent, and recurrent cervical cancer. Curr Opin Obstet Gynecol 2014; 26: 314-21.
12. FDA Approves First Drug Treatment for Late-Stage Cervical Cancer. U.S. Food and Drug Administration. 2006-06-15. Retrieved 2007-12-02.
13. Lakhani SA, Masud A, Kuida K, Porter GA Jr, Booth CJ, Mehal WZ, Inayat I, Flavell RA. Caspases 3 and 7: Key mediators of mitochondrial events of apoptosis. Science 2006; 311: 847-851.
14. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J, Johnson DH. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002; 346: 92-98.
15. Stewart DJ. Mechanisms of resistance to cisplatin and carboplatin. Crit Rev Oncol Hematol 2007; 63: 12-31.
16. Legault J, Pichette A. Potentiating effect of beta-caryophyllene on anticancer activity of alpha- humulene, isocaryophyllene and paclitaxel. J Pharm Pharmacol 2007; 59: 1643-7.
17. Kim SH, Park EJ, Lee CR, Chun JN, Cho NH, Kim IG, Lee S, Kim TW, Park HH, So I, Jeon JH. Geraniol induces cooperative interaction of apoptosis and autophagy to elicit cell death in PC-3 prostate cancer cells. Int J Oncol 2012; 40: 1683-90.
18. Miean KH, Mohamed S. Flavonoid (Myricetin, Quercetin, Kaempferol, Luteolin, and Apigenin) Content of Edible Tropical Plants. J Agric Food Chem 2001; 49: 3106-12.
19. Maggiolini M, Recchia AG, Bonofiglio D, Catalano S, Vivacqua A, Carpino A, Rago V, Rossi R, Andò S. The red wine phenolicspiceatannol and myricetin act as agonists for estrogen receptor in human breast cancer cells. J Mol Endocrinol 2005; 35: 269-81.
20. Knekt P, Kumpulainen J, Järvinen R, Rissanen H, Heliövaara M, Reunanen A, Hakulinen T, Aromaa A. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 2002; 76: 560-8.
21. Nöthlings U, Murphy SP, Wilkens LR, Henderson BE, Kolonel LN. Flavonols and pancreatic cancer risk: the multiethnic cohort study. Am J Epidemiol 2007; 166: 924-31.
22. Tan KH, Nishida R. Methyl eugenol: Its occurrence, distribution, and role in nature, especially in relation to insect behavior andpollination. J Insect Sci 2011; 12: 56.
23. Koezuka Y, Honda G, Tabata M. Genetic control of phenylpropanoids in Perillafrutescens. Phytochemistry 1986; 25: 2085-2087.
24. Yoshizumi N, Fujiwara J, Yoshizaki A, Sato M, Sakai R, Nishiya I. Cytokinetic effects of carboplatin and cisplatin on a human ovarian cancer cell line. Hum Cell 1988; 1: 301-307.